Skip to main content
Erschienen in: Graefe's Archive for Clinical and Experimental Ophthalmology 5/2004

01.05.2004 | Clinical Investigation

Glaucoma and mortality

verfasst von: Kirsti Grødum, Anders Heijl, Bo Bengtsson

Erschienen in: Graefe's Archive for Clinical and Experimental Ophthalmology | Ausgabe 5/2004

Einloggen, um Zugang zu erhalten

Abstract

Purpose

To compare mortality rates in glaucoma patients and matched controls from a large population screening as well as glaucoma patients diagnosed through routine clinical examination (self-selected patients).

Methods

A population-based screening of 32,918 elderly citizens of Malmö was conducted between 1992 and 1997. Individuals with newly detected, previously untreated open-angle glaucoma were identified. Two controls of the same age and gender were chosen among the screening negative participants for each patient. From the same birth cohorts, glaucoma patients seen in routine clinical practice (self-selected patients) were identified through retrospective examination of patient records from the Eye Department at Malmö University Hospital. The number and time of deaths for each group were determined based on centrally administered registers.

Results

Mean follow-up time was 7.75 years. Five-year mortality did not differ significantly between the groups, and was 9.2% among glaucoma patients from the screening (n=402), and 11.9% among the controls (n=804; p=0.7406). Self-selected glaucoma patients had a 5-year mortality of 8.5% (n=354), not significantly different from the screening-detected glaucoma patients (p=0.1361). Among glaucoma patients, neither IOP (p=0.1781) nor pseudoexfoliation (p=0.8882) was related to significantly increased mortality.

Conclusions

The results of this study strongly suggest that the life expectancy of glaucoma patients does not differ from the population at large.
Literatur
1.
Zurück zum Zitat Anderson DR (1989) Glaucoma: the damage caused by pressure.XLVI Edward Jackson memorial lecture. Am J Ophthalmol 108:485–495PubMed Anderson DR (1989) Glaucoma: the damage caused by pressure.XLVI Edward Jackson memorial lecture. Am J Ophthalmol 108:485–495PubMed
2.
Zurück zum Zitat Åsman P, Heijl A (1992a) Evaluation of methods for automated hemifield analysis in perimetry. Arch Ophthalmol 10:820–826 Åsman P, Heijl A (1992a) Evaluation of methods for automated hemifield analysis in perimetry. Arch Ophthalmol 10:820–826
3.
Zurück zum Zitat Åsman, Heijl A (1992b) Glaucoma Hemifield Test: automated visual field evaluation. Arch Ophthalmol 10:812–819 Åsman, Heijl A (1992b) Glaucoma Hemifield Test: automated visual field evaluation. Arch Ophthalmol 10:812–819
4.
Zurück zum Zitat Bengtsson B (1984) Survival of elderly ophthalmic out-patients. Acta Ophthalmol Scand 62:725–730 Bengtsson B (1984) Survival of elderly ophthalmic out-patients. Acta Ophthalmol Scand 62:725–730
5.
Zurück zum Zitat Borger PH, Van Leeuwen R, Hulsman CAA et al. (2003) Is there a direct association between age-related eye disease and mortality? Ophthalmology 110:1292–1296CrossRefPubMed Borger PH, Van Leeuwen R, Hulsman CAA et al. (2003) Is there a direct association between age-related eye disease and mortality? Ophthalmology 110:1292–1296CrossRefPubMed
6.
Zurück zum Zitat Chung HS, Harris A, Evans DW et al. (1999) Vascular aspects in the pathophysiology of glaucomatous optic neuropathy. Surv Ophthalmol 43:S43–S50CrossRefPubMed Chung HS, Harris A, Evans DW et al. (1999) Vascular aspects in the pathophysiology of glaucomatous optic neuropathy. Surv Ophthalmol 43:S43–S50CrossRefPubMed
7.
Zurück zum Zitat Cox DR (1972) Regression models and life tables. J R Stat Soc B 30:187–202 Cox DR (1972) Regression models and life tables. J R Stat Soc B 30:187–202
8.
Zurück zum Zitat Diggory P, Franks W (1996) Medical treatment of glaucoma: a reappraisal of the risks. Br J Ophthalmol 80:85–89PubMed Diggory P, Franks W (1996) Medical treatment of glaucoma: a reappraisal of the risks. Br J Ophthalmol 80:85–89PubMed
9.
Zurück zum Zitat Drance SM, Sweeney VP, Morgan RW et al (1973) Studies of factors involved in the production of low-tension glaucoma. Arch Ophthalmol 89:457–465PubMed Drance SM, Sweeney VP, Morgan RW et al (1973) Studies of factors involved in the production of low-tension glaucoma. Arch Ophthalmol 89:457–465PubMed
10.
Zurück zum Zitat Egge K, Zahl PH (1999) Survival of glaucoma patients. Acta Ophthalmol Scand 77:397–401PubMed Egge K, Zahl PH (1999) Survival of glaucoma patients. Acta Ophthalmol Scand 77:397–401PubMed
11.
Zurück zum Zitat Flammer J, Gasser P, Prünte C et al. (1992) The probable involvement of factors other than ocular pressure in the pathogenesis of glaucoma. Pharmacol Glaucoma 273–283 Flammer J, Gasser P, Prünte C et al. (1992) The probable involvement of factors other than ocular pressure in the pathogenesis of glaucoma. Pharmacol Glaucoma 273–283
12.
Zurück zum Zitat Grødum K, Heijl A, Bengtsson B (2002) A comparison of glaucoma patients identified through mass screening and in routine clinical practice. Acta Ophthal Scand 80:627–631CrossRef Grødum K, Heijl A, Bengtsson B (2002) A comparison of glaucoma patients identified through mass screening and in routine clinical practice. Acta Ophthal Scand 80:627–631CrossRef
13.
Zurück zum Zitat Gupta N, Weinreib R (1997) New definitions of glaucoma. Curr Opin Ophthalmol 8:38–41PubMed Gupta N, Weinreib R (1997) New definitions of glaucoma. Curr Opin Ophthalmol 8:38–41PubMed
14.
Zurück zum Zitat Harrison R, Kaufmann CS (1977) Clonidine: effects of a topically administered solution on intraocular pressure and blood pressure in open-angle glaucoma. Arch Ophthalmol 95:1368–1373PubMed Harrison R, Kaufmann CS (1977) Clonidine: effects of a topically administered solution on intraocular pressure and blood pressure in open-angle glaucoma. Arch Ophthalmol 95:1368–1373PubMed
15.
Zurück zum Zitat Hayreh SS, Zimmerman BM, Podhajsky P et al. (1994) Nocturnal arterial hypotension and its role in optic nerve head and ocular ischemic disorders. Am J Ophthalmol 117:603–624PubMed Hayreh SS, Zimmerman BM, Podhajsky P et al. (1994) Nocturnal arterial hypotension and its role in optic nerve head and ocular ischemic disorders. Am J Ophthalmol 117:603–624PubMed
16.
Zurück zum Zitat Heijl A, Leske MC, Bengtsson B et al. (2002) Reduction of intraocular pressure and glaucoma progression. Results from the Early Manifest Glaucoma Trial. Arch Ophthalmol 120:1268–1278PubMed Heijl A, Leske MC, Bengtsson B et al. (2002) Reduction of intraocular pressure and glaucoma progression. Results from the Early Manifest Glaucoma Trial. Arch Ophthalmol 120:1268–1278PubMed
17.
Zurück zum Zitat Hennis A, Wu SY, Nemesure B et al. (2003) Hypertension, diabetes, and longitudinal changes in intraocular pressure. Ophthalmology 110:908–914CrossRefPubMed Hennis A, Wu SY, Nemesure B et al. (2003) Hypertension, diabetes, and longitudinal changes in intraocular pressure. Ophthalmology 110:908–914CrossRefPubMed
18.
Zurück zum Zitat Hietanen J, Soisalon-Soininen S, Kivela T et al. (2002) Evaluation of the clinical association between exfoliation syndrome and abdominal aortic aneurysm. Acta Ophthalmol Scand 80:617–619CrossRefPubMed Hietanen J, Soisalon-Soininen S, Kivela T et al. (2002) Evaluation of the clinical association between exfoliation syndrome and abdominal aortic aneurysm. Acta Ophthalmol Scand 80:617–619CrossRefPubMed
19.
Zurück zum Zitat Hiller R, Podgor MJ, Sperduto RD et al. (1999) High introcular pressure and survival: the Framingham Studies. Am J Ophthalmol 128:440–445CrossRefPubMed Hiller R, Podgor MJ, Sperduto RD et al. (1999) High introcular pressure and survival: the Framingham Studies. Am J Ophthalmol 128:440–445CrossRefPubMed
20.
Zurück zum Zitat Hodapp E, Kolker AE, Kass MA et al. (1981) The effect of topical clonidine on intraocular pressure. Arch Ophthalmol 99:1208–1211PubMed Hodapp E, Kolker AE, Kass MA et al. (1981) The effect of topical clonidine on intraocular pressure. Arch Ophthalmol 99:1208–1211PubMed
21.
Zurück zum Zitat Kaplan EL, Meier P (1958) Nonparametric estimation from incomplete observations. J Am Stat Assoc 53:457–481 Kaplan EL, Meier P (1958) Nonparametric estimation from incomplete observations. J Am Stat Assoc 53:457–481
22.
Zurück zum Zitat Kass MA, Heuer DK, Higginbotham EJ et al. (2002) The Ocular Hyperrtension Treatment Study: a randomized trial determines that topical ocular hypotensive medication delays or prevents the onset of primary open-angle glaucoma. Arch Ophthalmol 120:701–713PubMed Kass MA, Heuer DK, Higginbotham EJ et al. (2002) The Ocular Hyperrtension Treatment Study: a randomized trial determines that topical ocular hypotensive medication delays or prevents the onset of primary open-angle glaucoma. Arch Ophthalmol 120:701–713PubMed
23.
Zurück zum Zitat Klein R, Klein BEK, Moss SE (1995) Age-related eye disease and survival. The Beaver Dam Eye Study. Arch Ophthalmol 113:333–339PubMed Klein R, Klein BEK, Moss SE (1995) Age-related eye disease and survival. The Beaver Dam Eye Study. Arch Ophthalmol 113:333–339PubMed
24.
Zurück zum Zitat Lee DJ, Gómez-Marín O, Lam BL et al. (2003) Glaucoma and survival. The National Health Interview Survey 1986–1994. Ophthalmology 110:1476–1483CrossRefPubMed Lee DJ, Gómez-Marín O, Lam BL et al. (2003) Glaucoma and survival. The National Health Interview Survey 1986–1994. Ophthalmology 110:1476–1483CrossRefPubMed
25.
Zurück zum Zitat Leske C, Heijl A, Hyman L et al (1999) Early Manifest Glaucoma Trial: design and baseline data. Ophthalmology 106:2144–2153PubMed Leske C, Heijl A, Hyman L et al (1999) Early Manifest Glaucoma Trial: design and baseline data. Ophthalmology 106:2144–2153PubMed
26.
Zurück zum Zitat Leske MC (2003) Glaucoma and mortality: A connection? Guest editorial. Ophthalmology 110:1473–1475CrossRefPubMed Leske MC (2003) Glaucoma and mortality: A connection? Guest editorial. Ophthalmology 110:1473–1475CrossRefPubMed
27.
Zurück zum Zitat Mitchell P, Smith W, Chey T et al. (1997) Open-angle glaucoma and diabetes: the Blue Mountains eye study, Australia. Ophthalmology 104:712–718PubMed Mitchell P, Smith W, Chey T et al. (1997) Open-angle glaucoma and diabetes: the Blue Mountains eye study, Australia. Ophthalmology 104:712–718PubMed
28.
Zurück zum Zitat Mitchell P, Wang JJ, Smith W (1997) Association of pseudoexfoliation syndrome with increased vascular risk. Am J Ophthalmol 124:685–687PubMed Mitchell P, Wang JJ, Smith W (1997) Association of pseudoexfoliation syndrome with increased vascular risk. Am J Ophthalmol 124:685–687PubMed
29.
Zurück zum Zitat Odberg T (1993) Visual field prognosis in early glaucoma: a long-term clinical follow-up. Acta Ophthalmol Scand 71:721–726 Odberg T (1993) Visual field prognosis in early glaucoma: a long-term clinical follow-up. Acta Ophthalmol Scand 71:721–726
30.
Zurück zum Zitat Odberg T, Jakobsen JE, Hultgren SJ et al. (2001) The impact of glaucoma on the quality of life of patients in Norway. I. Results from a self-administered questionnaire. Acta Ophthalmol Scand 79:116–120CrossRefPubMed Odberg T, Jakobsen JE, Hultgren SJ et al. (2001) The impact of glaucoma on the quality of life of patients in Norway. I. Results from a self-administered questionnaire. Acta Ophthalmol Scand 79:116–120CrossRefPubMed
31.
Zurück zum Zitat Repo L, Teräsvirta, Koivisto KJ (1993) Generalized transluminance of the iris and the frequency of the pseudoexfoliation syndrome in the eyes of transient ischemic attack patients. Ophthalmology 100:352–355PubMed Repo L, Teräsvirta, Koivisto KJ (1993) Generalized transluminance of the iris and the frequency of the pseudoexfoliation syndrome in the eyes of transient ischemic attack patients. Ophthalmology 100:352–355PubMed
32.
Zurück zum Zitat Ringvold A, Blika S, Sandvik L (1997) Pseudo-exfoliation and mortality. Acta Ophthalmol Scand 75:255–256PubMed Ringvold A, Blika S, Sandvik L (1997) Pseudo-exfoliation and mortality. Acta Ophthalmol Scand 75:255–256PubMed
33.
34.
Zurück zum Zitat Schuman JS (2000) Antiglaucoma medications. A review of safety and tolerability issues related to their use. Clin Ther 22:167–208CrossRefPubMed Schuman JS (2000) Antiglaucoma medications. A review of safety and tolerability issues related to their use. Clin Ther 22:167–208CrossRefPubMed
35.
Zurück zum Zitat Shrum KR, Hattenhauer MG, Hodge D (2000) Cardiovascular and cerebrovascular mortality associated with ocular pseudoexfoliation. Am J Ophthalmol 129:83–86CrossRefPubMed Shrum KR, Hattenhauer MG, Hodge D (2000) Cardiovascular and cerebrovascular mortality associated with ocular pseudoexfoliation. Am J Ophthalmol 129:83–86CrossRefPubMed
36.
Zurück zum Zitat Stewart WC, Osterman J (1998) Serum lipid physiology and the influence of glaucoma medications. Surv Ophthalmol 43:233–244CrossRefPubMed Stewart WC, Osterman J (1998) Serum lipid physiology and the influence of glaucoma medications. Surv Ophthalmol 43:233–244CrossRefPubMed
37.
Zurück zum Zitat Thorburn W, Lindblom B (1983) Survival time among patients with glaucomatous visual field defects. Acta Ophthalmol Scand 61:728–730 Thorburn W, Lindblom B (1983) Survival time among patients with glaucomatous visual field defects. Acta Ophthalmol Scand 61:728–730
38.
Zurück zum Zitat Tielsch Jm, Katz J, Sommer A et al. (1995) Hypertension, perfusion pressure, and primary open-angle glaucoma. A population-based assessment. Arch Ophthalmol 113:216–221PubMed Tielsch Jm, Katz J, Sommer A et al. (1995) Hypertension, perfusion pressure, and primary open-angle glaucoma. A population-based assessment. Arch Ophthalmol 113:216–221PubMed
39.
Zurück zum Zitat Wu SY, Nemesure B, Leske MC (2001) Observed versus indirect estimates of incidence of open-angle glaucoma. Am J Epidemiol 153:184–187CrossRefPubMed Wu SY, Nemesure B, Leske MC (2001) Observed versus indirect estimates of incidence of open-angle glaucoma. Am J Epidemiol 153:184–187CrossRefPubMed
Metadaten
Titel
Glaucoma and mortality
verfasst von
Kirsti Grødum
Anders Heijl
Bo Bengtsson
Publikationsdatum
01.05.2004
Verlag
Springer-Verlag
Erschienen in
Graefe's Archive for Clinical and Experimental Ophthalmology / Ausgabe 5/2004
Print ISSN: 0721-832X
Elektronische ISSN: 1435-702X
DOI
https://doi.org/10.1007/s00417-004-0858-2

Weitere Artikel der Ausgabe 5/2004

Graefe's Archive for Clinical and Experimental Ophthalmology 5/2004 Zur Ausgabe

Neu im Fachgebiet Augenheilkunde

Update Augenheilkunde

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.